Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I

International Journal of Cardiology

Volumn 187, Issue 1, 2015, Pages 256-263

  Krintus, Magdalena ^a   Kozinski, Marek ^a   Boudry, Pascal ^b   Lackner, Karl ^c   Lefèvre, Guillaume ^d   Lennartz, Lieselotte ^e   Lotz, Johannes ^c   Manysiak, Slawomir ^a   Shih, Jessie ^f   Skadberg, Øyvind ^g   Chargui, Ahmed Taoufik ^d   Sypniewska, Grazyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Collegium Medicum ^*  (Belgium)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d HÔPITAL TENON   (France)

^e ABBOTT GMBH AND CO KG   (Germany)

^f ABBOTT LABORATORIES   (United States)

^g STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

99th percentile url; High sensitivity troponin; Normality

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN I; BIOLOGICAL MARKER;

99TH PERCENTILE UPPER REFERENCE LIMIT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; SEX DIFFERENCE; UNIVARIATE ANALYSIS; BLOOD; CLINICAL TRIAL; EUROPE; MIDDLE AGED; MULTICENTER STUDY; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY;

ADULT; BIOMARKERS; COHORT STUDIES; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84929353446     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.282     Document Type: Article

References (42)

1. K. Thygesen, J.S. Alpert, A.S. Jaffe, et al., Third universal definition of myocardial infarction, J. Am. Coll. Cardiol. 60 (2012) 1581-1598.
2. K. Thygesen, J. Mair, E. Giannitsis, et al., How to use high-sensitivity cardiac troponins in acute cardiac care, Eur. Heart J. 33 (2012) 2252-2257.
3. J.T. Neumann, A.S. Havulinna, T. Zeller, et al., Comparison of three troponins as predictors of future cardiovascular events-prospective results from the FINRISK and BiomaCaRE studies, PLoS One 9 (2014) e90063.
4. F.S. Apple, P.O. Collinson, Analytical characteristics of high-sensitivity cardiac troponin assays, Clin. Chem. 58 (2012) 54-61.
5. Y. Sandoval, F.S. Apple, The global need to define normality: the 99th percentile value of cardiac troponin, Clin. Chem. 60 (2014) 455-462.
6. P.O. Collinson, Y.M. Heung, D. Gaze, et al., Influence of population selection on the 99th percentile reference value for cardiac troponin assays, Clin. Chem. 58 (2012) 219-225.
7. T. Keller, F. Ojeda, T. Zeller, et al., Defining a reference population to determine the 99th percentile of a contemporary sensitive cardiac troponin I assay, Int. J. Cardiol. 167 (2013) 1423-1429.
8. Clinical Laboratory Standards Institute, Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, Third Edition Clinical and Laboratory Standards Institute, Wayne, PA, 2010. EP28-A3c().
9. S. Yusuf, S. Hawken, S. Ounpuu, et al., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case- control study, Lancet 364 (2004) 937-952.
10. F.M. Task, J. Perk, G. De Backer, et al., European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR), Eur. Heart J. 33 (2012) 1635-1701.
11. F.M. Costa, J. Ferreira, C. Aguiar, et al., Impact of ESC/ACCF/AHA/WHF universal definition of myocardial infarction on mortality at 10 years, Eur. Heart J. 33 (2012) 2544-2550.
12. R.B. Schnabel, P.S. Wild, A. Schulz, et al., Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study, Hypertension 60 (2012) 288-295.
13. P. Rustad, P. Simonsson, P. Felding, et al., Nordic Reference Interval Project Bio-bank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals, Scand. J. Clin. Lab. Invest. 64 (2004) 431-438.
14. J.J. McMurray, S. Adamopoulos, S.D. Anker, et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Eur. J. Heart Fail. 14 (2012) 803-869.
15. The International Expert Committee, International expert committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care 32 (2009) 1327-1334.
16. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease, Kidney Int. Suppl. 3 (2013) 1-150 (http://www.kdigo.org/clinical- practice-guidelines/pdf/CKD/KDIGO-2012-CKD-GL.pdf (Accessed May 25, 2014)).
17. Abbott ARCHITECT STAT High Sensitive Troponin-I. Package Insert2013. (G1-0139/R02).
18. A.S. Levey, J.P. Bosch, J.B. Lewis, et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group, Ann. Intern. Med. 130 (1999) 461-470.
19. A.S. Levey, J. Coresh, T. Greene, et al., Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann. Intern. Med. 145 (2006) 247-254.
20. A.H. Reed, R.J. Henry, W.B. Mason, Influence of statistical method used on the resulting estimate of normal range, Clin. Chem. 17 (1971) 275-284.
21. International Federation of Clinical Chemistry and Laboratory Medicine, Troponin Assay Analytical Characteristics, http://www.ifcc.org/media/245202/IFCC%20Troponin%20I%20and%20T%20(ng-L%20units)-%20update%20December%202013.pdf2013 (Accessed August 2, 2014).
22. E.P. Cardinaels, A.M. Mingels, L.H. Jacobs, et al., A comprehensive review of upper reference limits reported for (high-)sensitivity cardiac troponin assays: the challenges that lie ahead, Clin. Chem. Lab. Med. 50 (2012) 791-806.
23. P.M. McKie, D.M. Heublein, C.G. Scott, et al., Defining high-sensitivity cardiac troponin concentrations in the community, Clin. Chem. 59 (2013) 1099-1107.
24. G. Koerbin, W.P. Abhayaratna, J.M. Potter, et al., Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays, Clin. Biochem. 46 (2013) 1636-1643.
25. P.S. Horn, A.J. Pesce, B.E. Copeland, A robust approach to reference interval estimation and evaluation, Clin. Chem. 44 (1998) 622-631.
26. P.S. Horn, A.J. Pesce, B.E. Copeland, Reference interval computation using robust vs parametric and nonparametric analyses, Clin. Chem. 45 (1999) 2284-2285.
27. M. Krintus, M. Kozinski, P. Boudry, et al., European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay, Clin. Chem. Lab. Med. 52 (2014) 1657-1665.
28. P. Collinson, Reference ranges for cardiac troponin in the era of high sensitivity assays, Clin. Biochem. 46 (2013) 1629-1630.
29. P.E. Hickman, B. Lindahl, J.M. Potter, et al., Is it time to do away with the 99th percentile for cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk? Clin. Chem. 60 (2014) 734-736.
30. K.M. Eggers, P. Venge, B. Lindahl, et al., Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population, J. Am. Coll. Cardiol. 61 (2013) 1906-1913.
31. G. Koerbin, J.M. Potter, W.P. Abhayaratna, et al., The distribution of cardiac troponin I in a population of healthy children: lessons for adults, Clin. Chim. Acta 417 (2013) 54-56.
32. T.C. Aw, S.K. Phua, S.P. Tan, Measurement of cardiac troponin I in serum with a new high-sensitivity assay in a large multi-ethnic Asian cohort and the impact of gender, Clin. Chim. Acta 422 (2013) 26-28.
33. F.S. Apple, R. Ler, M.M. Murakami, Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population, Clin. Chem. 58 (2012) 1574-1581.
34. G. Koerbin, J. Tate, J.M. Potter, et al., Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population, Clin. Chem. Lab. Med. 50 (2012) 871-878.
35. N.L. Mills, High-STEACS: high-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in women, ESC Congress 2013, 2013 (http://www.escardio.org/congresses/esc-2013/congress-reports/Pages/711-High-STEACS.aspx#.U6dRGUBAfjI (Accessed 2 August 2014)).
36. M.O. Gore, S.L. Seliger, C.R. deFilippi, et al., Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay, J. Am. Coll. Cardiol. 63 (2014) 1441-1448.
37. J. Rubin, K. Matsushita, C.M. Ballantyne, et al., Chronic hyperglycemia and subclinical myocardial injury, J. Am. Coll. Cardiol. 59 (2012) 484-489.
38. H.D. White, Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J. Am. Coll. Cardiol. 57 (2011) 2406-2408.
39. E.A. Bohula May, M.P. Bonaca, P. Jarolim, et al., Prognostic performance of a highsensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome, Clin. Chem. 60 (2014) 158-164.
40. N.L. Mills, K.K. Lee, D.A. McAllister, et al., Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study, BMJ 344 (2012).
41. P. Krishnaswamy, E. Lubien, P. Clopton, et al., Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction, Am. J. Med. 111 (2001) 274-279.
42. K. Yamamoto, J.C. Burnett Jr., E.A. Bermudez, et al., Clinical criteria and biochemical markers for the detection of systolic dysfunction, J. Card. Fail. 6 (2000) 194-200.